Severe hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with HIV/AIDS: a case report
- PMID: 40486544
- PMCID: PMC12140668
- DOI: 10.1097/MS9.0000000000003350
Severe hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with HIV/AIDS: a case report
Abstract
Introduction and importance: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder marked by immune system dysregulation, leading to a severe inflammatory response that can affect multiple organs. It can be triggered by infections, and HLH secondary to disseminated histoplasmosis remains poorly understood, with uncertain guidelines on immunosuppressive therapy. Early diagnosis and prompt treatment are critical in preventing fatal outcomes, but challenges in diagnosis complicate this process, particularly in immunocompromised patients.
Case presentation: A 51-year-old immunocompromised woman with asthma, gastritis, and anemia presented with fever, malaise, weight loss, and respiratory symptoms. Initial workup revealed pancytopenia, elevated ferritin levels, and an HIV diagnosis with a low CD4 count. Suspecting HLH, she was treated with antiretrovirals, antifungals, and steroids. Her condition worsened, and she developed MRSA sepsis, metabolic acidosis, and multiorgan failure. Histoplasmosis was confirmed, and treatment with liposomal amphotericin B was initiated. Unfortunately, she suffered a cardiac arrest and died on day 11. Postmortem findings confirmed disseminated histoplasmosis-induced HLH.
Clinical discussion: HLH is a rare but severe immune activation disorder causing systemic inflammation, multi-organ failure, and high mortality. It can be primary (genetic) or secondary. Diagnosis follows HLH-2004 criteria, and treatment includes immunosuppressive therapy and hematopoietic cell transplantation.
Conclusion: This case illustrates the complexities of diagnosing HLH in immunocompromised patients. Delays in obtaining critical lab results and initiating treatment contributed to the patient's rapid deterioration. Early intervention and careful monitoring are crucial in managing such complex cases, where timely diagnosis can significantly impact patient outcomes.
Keywords: case report; cytokine storm; disseminated histoplasmosis; fever of unknown origin; hemophagocytic lymphohistiocytosis.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. None.
Figures
Similar articles
-
Hemophagocytic Lymphohistiocytosis Due to Disseminated Histoplasmosis in a Young Patient with AIDS.J Glob Infect Dis. 2025 Feb 24;17(1):63-65. doi: 10.4103/jgid.jgid_150_24. eCollection 2025 Jan-Mar. J Glob Infect Dis. 2025. PMID: 40290200 Free PMC article.
-
Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis in HIV Seronegative Patients: A Case Report and Review of the Literature.Front Cell Infect Microbiol. 2022 Jun 16;12:847950. doi: 10.3389/fcimb.2022.847950. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35782129 Free PMC article. Review.
-
Survival Against the Odds-Hemophagocytic Lymphohistiocytosis Amidst the Shadows of Disseminated Histoplasmosis: A Case Report and Literature Review.J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241258074. doi: 10.1177/23247096241258074. J Investig Med High Impact Case Rep. 2024. PMID: 38813977 Free PMC article. Review.
-
Hemophagocytic Lymphohistiocytosis During HIV Infection in Cayenne Hospital 2012-2015: First Think Histoplasmosis.Front Cell Infect Microbiol. 2020 Sep 24;10:574584. doi: 10.3389/fcimb.2020.574584. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33072627 Free PMC article.
-
Hemophagocytic Lymphohistiocytosis (HLH) in a Patient with Disseminated Histoplasmosis.Case Rep Hematol. 2020 Jul 18;2020:5638262. doi: 10.1155/2020/5638262. eCollection 2020. Case Rep Hematol. 2020. PMID: 32765915 Free PMC article.
References
-
- Henter J-I. Hemophagocytic lymphohistiocytosis. N Engl J Med 2025;392:584–98. - PubMed
-
- Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol 2013;161:609–22. - PubMed
-
- Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Practice & Research Clinical Rheumatology 2020;34:101515. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous